A Pilot Study to Determine the Safety and Efficacy of Using Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment
Description:
Research has suggested that high levels of erythropoietin (EPO) decreases the ability of
infused umbilical cord stem cells to home to the bone marrow. The investigators will
investigate the use of hyperbaric oxygen (HBO) therapy to decrease the plasma concentrations
of EPO prior to UBC transplant and evaluate the resulting impact on UBC homing.
Condition:
Acute Myeloid Leukemia
Treatment:
Administration of hyperbaric oxygen
Start Date:
June 2013
Sponsor:
University of Kansas Medical Center
For More Information:
https://clinicaltrials.gov/show/NCT02099266